Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.

WAXMAN J; MAN A; HENDRY W F; WHITFIELD H N; BESSER G M; TIPTAFT R C; PARIS A M I; OLIVER R T D

Art

J-GLOBAL ID：200902052407669187 Reference number：86A0129811

Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.

ゴナドトロピン放出ホルモンの持続性アナログで治療した進行前立せんがん患者における初期のしゅよう増悪の重要性

Publisher site Copy service
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=86A0129811&from=J-GLOBAL&jstjournalNo=E0828A") }}

Author (8)： , , , , , , ,
Material：
Volume： 291 Issue： 6506 Page： 1387-1388 Publication year： Nov. 16, 1985
JST Material Number： E0828A ISSN： 1759-2151 Document type： Article
Article type：短報 Country of issue： United Kingdom (GBR) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=86A0129811&from=J-GLOBAL&jstjournalNo=E0828A") }}

Clinical application of drugs acting on endocrine system and genital organ , Other hormones of verterbrates , Urogenital tumors(=neoplasms) , Drug therapy(=pharmacotherapy)for cardiovascular system diseases

, , , , , , , , ,

Return to Previous Page